Last edition
News about "autoimmune diseases "
AbbVie to Acquire Nimble Therapeutics to Expand its Immunology Pipeline
AbbVie will acquire Nimble's peptide synthesis, screening, and optimization platform, which uses proprietary technology to help drive rapid discovery and optimization of peptide candidates for a range of targets.
Autoimmune Diseases | 18/12/2024 | By Aishwarya
AbbVie and FutureGen to Develop Next-Gen Therapy for Inflammatory Bowel Disease
AbbVie has signed a license agreement with FutureGen Biopharmaceutical to develop FG-M701, a next-generation TL1A antibody for the treatment of IBD currently in preclinical development.
Autoimmune Diseases | 14/06/2024 | By Aishwarya
Vertex Signs Agreement to Acquire Alpine Immune Sciences
Vertex Pharmaceuticals has signed a definitive agreement with Alpine Immune Sciences, a biotechnology company focused on discovering and developing innovative, protein-based immunotherapies.
Autoimmune Diseases | 11/04/2024 | By Aishwarya | 200
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy